Diabetic retinopathy is caused by prolonged high blood sugar damaging the tiny blood vessels that supply the retina, the light-sensitive tissue at the back of your eye. The damage begins at a microscopic level, often years before you notice any changes in vision, and progresses through a chain of events that ultimately starves retinal tissue of oxygen and triggers the growth of fragile, leaky new blood vessels.
How High Blood Sugar Damages Retinal Blood Vessels
The retina depends on a dense network of capillaries to deliver oxygen and nutrients. These capillaries are lined with endothelial cells and wrapped by support cells called pericytes, which keep the vessel walls stable and control blood flow. Chronic high blood sugar sets off a cascade of chemical changes that attack both cell types.
Excess glucose in the bloodstream reacts with proteins, fats, and DNA to form compounds called advanced glycation end-products. These compounds accumulate in retinal tissue and cause direct harm: they trigger pericyte death, thicken the structural walls of capillaries, and loosen the tight seals between endothelial cells. Once those seals weaken, fluid and blood components leak into the surrounding retinal tissue.
High glucose also depletes one of the cell’s key antioxidant defenses by diverting it into an alternative sugar-processing route (the polyol pathway). This leaves cells vulnerable to oxidative damage from reactive oxygen species, which are elevated in the diabetic retina and contribute to pericyte loss, vessel leakage, and the formation of hollow “ghost capillaries” that no longer carry blood.
Why Pericyte Loss Is the First Domino
Early pericyte death is a hallmark of diabetic retinopathy and one of its earliest detectable changes. The mechanism involves a stress response inside the cell: high glucose ramps up production of nitric oxide, which modifies a metabolic enzyme and sends it into the cell nucleus with a partner protein. Once there, the complex degrades proteins essential for cell survival, pushing the pericyte toward programmed death.
When pericytes die, the capillaries they once stabilized become structurally weak. Without their regulatory influence, endothelial cells begin to proliferate abnormally, forming tiny bulges in the vessel wall known as microaneurysms. These are the first visible sign an eye doctor can detect during a retinal exam. The abandoned capillaries eventually collapse into empty tubes of basement membrane, cutting off blood supply to patches of the retina.
The Shift From Early to Advanced Disease
Diabetic retinopathy progresses through two broad phases. In the non-proliferative phase, damage is confined to existing blood vessels. It starts with microaneurysms alone (mild), advances to scattered hemorrhages and other vascular abnormalities (moderate), and reaches a severe stage when hemorrhages appear across all four quadrants of the retina or veins begin to bead and swell. At this point, large areas of the retina are losing their blood supply.
When enough retinal tissue becomes oxygen-starved, the eye mounts a rescue response that ultimately makes things worse. Cells release vascular endothelial growth factor (VEGF), a signaling molecule that drives the growth of new blood vessels. VEGF prompts endothelial cells to multiply, dissolve surrounding tissue to create space, and migrate outward to form new capillaries. This marks the transition to proliferative diabetic retinopathy.
The problem is that these new vessels are poorly constructed. They lack the tight junctions and pericyte coverage of healthy capillaries, making them extremely fragile. They grow along the retinal surface and into the gel-like vitreous cavity of the eye, where they can bleed without warning. A large vitreous hemorrhage can cause sudden, severe vision loss. Over time, scar tissue can form along these vessels and pull on the retina, potentially causing detachment.
VEGF’s Role in Leakage and Vision Loss
VEGF doesn’t just drive new vessel growth. It also plays a central role in the swelling that threatens central vision. VEGF increases the permeability of existing retinal capillaries by breaking down the proteins that hold endothelial cells together. One of these seal proteins, occludin, gets chemically modified and marked for destruction when VEGF levels rise. High glucose conditions independently reduce levels of other junction proteins in the retina, compounding the problem.
When the blood-retina barrier breaks down in the central part of the retina (the macula), fluid accumulates and causes diabetic macular edema. This can happen at any stage of retinopathy and is one of the most common causes of vision loss in people with diabetes.
Blood Sugar Control Is the Strongest Risk Factor
The single most important driver of diabetic retinopathy is how high your blood sugar runs over time, measured by HbA1c. A large Swedish population study found that for every 1 percentage point increase in HbA1c, the odds of developing any retinopathy rose by 51% over 8 to 10 years of follow-up. Over 16 to 20 years, that same 1-point increase nearly tripled the odds of proliferative disease.
Duration of diabetes matters too. The longer you’ve had diabetes, the more cumulative exposure your retinal vessels have endured. Type 1 diabetes guidelines reflect this: initial eye screening is recommended five years after diagnosis, since retinopathy rarely develops before that point. For type 2 diabetes, screening should happen at the time of diagnosis because many people have had elevated blood sugar for years before they’re formally diagnosed.
If screening shows no retinopathy and blood sugar is well controlled, exams every one to two years are generally sufficient. Any level of retinopathy calls for at least annual monitoring, and progressing or sight-threatening disease requires more frequent evaluation.
Blood Pressure and Cholesterol Add Fuel
High blood sugar may be the primary cause, but it doesn’t act alone. Chronic high blood pressure independently damages retinal microvasculature by putting mechanical stress on already-weakened capillary walls. Among people with severe hypertension, the prevalence of retinal damage reaches nearly 85%, compared to about 25% in those with mild hypertension.
Elevated LDL cholesterol also contributes. Higher LDL levels correlate with reduced microvascular density and blood flow in the retina, along with areas of capillary non-perfusion, meaning patches where blood simply stops reaching. Managing both blood pressure and cholesterol slows retinopathy progression independently of blood sugar control.
Why Pregnancy Can Accelerate Retinopathy
Pregnancy poses a unique risk for women with pre-existing diabetes. Hormonal shifts, changes in blood volume, and alterations in how retinal blood vessels regulate themselves can all worsen retinopathy. But one of the most counterintuitive triggers is rapidly improving blood sugar control early in pregnancy.
Women who achieve the greatest reductions in HbA1c during the first trimester face the highest risk of retinopathy progression. The likely explanation: when blood sugar drops quickly, retinal blood flow decreases, and small vessels that were narrowed but still functioning can close entirely, creating new areas of oxygen deprivation. Pre-eclampsia and pregnancy-induced hypertension further compound the risk. Women with diabetes who are pregnant or planning pregnancy benefit from retinal evaluation before conception and close monitoring throughout.
The Inflammation Connection
Diabetic retinopathy is increasingly understood as an inflammatory disease, not purely a vascular one. In the diabetic retina, white blood cells become stickier and adhere to vessel walls, releasing inflammatory compounds that accelerate capillary degeneration. Elevated VEGF itself acts as a pro-inflammatory signal, not just a growth factor, creating a feedback loop: vessel damage triggers inflammation, which triggers more VEGF, which causes more damage.
Enzymes that produce inflammatory molecules called leukotrienes are active in the diabetic retina and promote capillary death. Nitric oxide production, normally a protective mechanism, becomes harmful in excess, contributing to vascular injury in the early stages of the disease. These overlapping inflammatory and metabolic pathways help explain why retinopathy can progress even when blood sugar is reasonably well managed, and why treatment strategies increasingly target inflammation alongside blood vessel growth.